Bacitracin and gramicidin
Murk, Jean-Luc Kluytmans, Jan
Murk, Jean-Luc
Kluytmans, Jan
Citations
Altmetric:
Series / Report no.
Open Access
Type
Book chapter
Language
en
Date of publication
2018-12-04
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Bacitracin and gramicidin
Translated Title
Published in
In: ML Grayson, S Cosgrove, S Crowe, et al. (eds.). Kucers' the use of antibiotics : a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs (7th edition). - 2017; pp. 1454-1459
Abstract
Bacitracin was first isolated in 1943 from a strain of Bacillus spp. that was originally classified as Bacillus subtilis (Johnson et al., 1945) but is now known as Bacillus licheniformis (Katz and Demain, 1977). The molecular formula is C66H103N17O16S (Figure 83.1), and it has a molecular weight of 1422.7. Bacitracin consists of a mixture of related nonribosomally synthesized cyclic metallopolypeptides (bacitracin A, B, and C and several minor components), and variations in molecular weight have been described. Bacitracin A is the main component of bacitracin preparations (Stone and Strominger, 1971). It has a bactericidal effect on most Gram-positive bacteria owing to its interference with bacterial cell wall formation. In humans, bacitracin’s toxicity mainly restricts its application to topical use. Bacitracin was (and sometimes still is) used as growth promoter in animal husbandry.
Description
Publisher
Boca Raton : CRC Press, 2017